Urs von Holzen Selected Research

Urs von Holzen Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 06/2005
7	Adenocarcinoma 12/2021 - 01/2018
5	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 08/2005
3	Colorectal Neoplasms (Colorectal Cancer) 06/2021 - 06/2014
2	Colonic Neoplasms (Colon Cancer) 08/2022 - 06/2014
2	Stomach Neoplasms (Stomach Cancer) 12/2021 - 01/2021
2	Melanoma (Melanoma, Malignant) 04/2009 - 06/2005
1	Subcutaneous Emphysema 04/2021
1	Wounds and Injuries (Trauma) 04/2021
1	Prostatic Neoplasms (Prostate Cancer) 12/2020
1	Hemorrhage 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019
1	Pancreatitis 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Ascites 01/2017
1	Colic (Abdominal Cramps) 05/2016
1	Colonic Pseudo-Obstruction (Ogilvie Syndrome) 05/2016
1	Intestinal Volvulus (Volvulus) 05/2016
1	Flatulence 05/2016
1	Carcinoma (Carcinomatosis) 08/2014
1	Surgical Wound Infection 05/2014
1	Hernia (Hernias) 01/2014
1	Constipation 01/2014
1	Pathologic Constriction (Stenosis) 01/2014
1	Disease Progression 02/2010
1	Infections 08/2005

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 01/2022 - 06/2005
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 01/2017
2	ChemokinesIBA 01/2022 - 06/2021
2	130-nm albumin-bound paclitaxelIBA 12/2021 - 10/2019
2	Albumin-Bound Paclitaxel FDA Link 01/2021 - 04/2018
2	GSK 1363089IBA 01/2021 - 11/2019
2	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2018
2	Interleukin-15 (Interleukin 15)IBA 04/2009 - 06/2005
2	AntigensIBA 04/2009 - 06/2005
2	MART-1 AntigenIBA 04/2009 - 06/2005
2	Interleukin-2 (IL2)IBA 04/2009 - 06/2005
2	Interleukin-7 (Interleukin 7)IBA 04/2009 - 06/2005
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2021
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 12/2021
1	NestinIBA 06/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021
1	BMS 754807IBA 01/2021
1	alvocidib (flavopiridol)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 12/2020
1	Epinephrine (Adrenaline)FDA LinkGeneric 12/2020
1	AndrogensIBA 12/2020
1	Hemostatics (Antihemorrhagics)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	LigandsIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Lapatinib (GW572016)FDA Link 11/2019
1	Phosphotransferases (Kinase)IBA 11/2019
1	tyrosine receptor (receptor, tyrosine)IBA 11/2019
1	trametinibIBA 10/2019
1	Gemcitabine FDA Link 10/2019
1	MK 2206IBA 10/2019
1	cremophorIBA 04/2018
1	Atrial Natriuretic Factor (ANF)IBA 01/2018
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018
1	proadrenomedullinIBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Peroxidase (Myeloperoxidase)IBA 12/2015
1	Macrophage Colony-Stimulating FactorIBA 06/2014
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 06/2014
1	AntibodiesIBA 06/2014
1	Coloring Agents (Dyes)IBA 06/2014
1	DNA (Deoxyribonucleic Acid)IBA 02/2010
1	Histones (Histone)IBA 02/2010
1	Cyclin AIBA 02/2010
1	HLA-A*02:01 antigenIBA 04/2009
1	Saline SolutionIBA 08/2005
1	LuciferasesIBA 08/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2005
1	Tetracycline (Achromycin)FDA LinkGeneric 08/2005
1	eIF-2 Kinase (eIF 2 Kinase)IBA 08/2005
1	Double-Stranded RNA (RNA, Double Stranded)IBA 08/2005
1	Phosphates (Orthophosphate)IBA 08/2005

Therapy/Procedure

7	Therapeutics 12/2021 - 01/2017
3	Drug Therapy (Chemotherapy) 12/2021 - 01/2014
2	Intraperitoneal Injections 01/2018 - 01/2017
2	Conservative Treatment 05/2016 - 01/2014
2	Anesthesia 08/2014 - 05/2014
1	Intravenous Injections 08/2022
1	Induction Chemotherapy 01/2022
1	Neoadjuvant Therapy 01/2022
1	Laparotomy 05/2016
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 08/2014
1	Appendectomy 01/2014
1	Immunotherapy 04/2009